[ U.S. CDMRP – Melanoma Research Program Technology Development Partnership Award | Research Funding ]
Event details
| Date | 22.06.2020 |
| Category | Call for proposal |
Aim: Through the Congressionally Directed Medical Research Program (CDMRP), the Department of Defense is announcing the Melanoma Research Program (MRP) Awards. The MRP Technology Development Partnership Award is designed to encourage investigations into emerging technologies to assist in the detection, diagnosis, prognosis, and ultimately treatment of melanoma. The intent of the TDPA is to foster collaboration between biomedical sciences and physical sciences (e.g., bioengineering, computational science, imaging science, and bioinformatics) and spur progress in the development of computational approaches, bioinformatics, devices, or knowledge based products or outcomes, etc.
The critical components of this award mechanism are as follows:
Funding: max. $700’000
Duration: 3 years
Eligibility: Applicants from international organizations or institutions are eligible to apply, and there are no citizenship restrictions. The PI must have a faculty level appointment or equivalent.
How to Apply: Pre-applications are submitted through the eBRAP platform. They should contain contact information, a preproposal narrative, and a list of collaborators and key personnel as suggested on the platform. Full applications (by invitation) will be made via a Grants.gov workspace. Full application packages can be downloaded from Grants.gov at any time.
Pre-Application Deadline: 22-June-2020, 5:00 p.m. EST
Full Application Deadline: 24-September-2020, 11:59 p.m. EST
Grants.gov Funding Opportunity Number: W81XWH-20-MRP-TDPA
Further information
The critical components of this award mechanism are as follows:
- Impact: The TDPA is intended to support research that demonstrates the potential to have a major impact on patient outcomes.
- Preliminary Data: The TDPA is intended to support cross-disciplinary investigations that advance the melanoma research field forward by utilizing previous research findings.
- Cross-Disciplinary Personnel and Collaboration: The success of the project depends on the unique skills and contributions of each collaborator. One PI must be from the biomedical field and one PI must be from a physical science field.
- Technological Design: The technological design of the research should integrate tenets from a biomedical field with a physical science field. Techniques ranging from fields such as quantitative science, mathematics, computer science, or engineering, may be merged with biomedical sciences to answer a specific need in the study of melanoma (diagnostics, high risk markers, dormancy, and metastasis).
Funding: max. $700’000
Duration: 3 years
Eligibility: Applicants from international organizations or institutions are eligible to apply, and there are no citizenship restrictions. The PI must have a faculty level appointment or equivalent.
How to Apply: Pre-applications are submitted through the eBRAP platform. They should contain contact information, a preproposal narrative, and a list of collaborators and key personnel as suggested on the platform. Full applications (by invitation) will be made via a Grants.gov workspace. Full application packages can be downloaded from Grants.gov at any time.
Pre-Application Deadline: 22-June-2020, 5:00 p.m. EST
Full Application Deadline: 24-September-2020, 11:59 p.m. EST
Grants.gov Funding Opportunity Number: W81XWH-20-MRP-TDPA
Further information
- To see the program announcement, navigate to the search page on Grants.gov and search for the Opportunity Number W81XWH-20-MRP-TDPA
- For questions about the eBRAP or Grants.gov platforms, contact the Research Office.
Practical information
- General public
- Free